Fertility Disorders Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled Study to Confirm the Positive Effect of Fertibiome® (Ligilactobacillus Salivarius PS11610) on the Female Genital Tract Microbiota of Couples or Women With Fertility Disorders.
In the last decades, numerous publications have broken the old paradigm that considered the urogenital tracts as sterile, demonstrating that microorganisms present in the urogenital tract represent the 9% of the whole human microbiome. Healthy urogenital microbiome improves implantation rate and pregnancy outcomes, whereas 40% of dysbiosis prevalence is observed in women under assisted reproductive treatment (ART). Infertility causes are associated with male, female, or combined failure. It has been shown that oral probiotic treatment, mainly with Lactobacillus, recovers a healthy vaginal microbiota without safety concerns. An interventional, randomized, double-blind, placebo-controlled study will be conducted to confirm the positive effect of the commercial probiotic product Fertibiome® on the vaginal dysbiosis of couples or women with fertility disorders. The duration of the study will be of 6 months approximately, including 6 months of product intake. In case of pregnancy during intervention, women will continue their participation until week 12 of gestation. Participants will be randomly assigned to one of the two study groups: control group with placebo administration or probiotic administration group. Women will take 1 capsule every 12 hours and men 1 per day. In case of women participating alone they will take 1 capsule every 12 hours. In case of pregnancy, only women will continue taking 1 capsule per day for the first 12 weeks.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05634850 -
Evaluating the Usability of the Product Kinder System Trial, Home Based Hormone for In-Vitro Fertilization (IVF) Monitoring System.
|
||
| Completed |
NCT03803228 -
Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders
|
Phase 3 | |
| Active, not recruiting |
NCT06053827 -
Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
|
||
| Recruiting |
NCT03480412 -
Second Step Protocol in Poor Ovarian Responder (POR)
|
||
| Not yet recruiting |
NCT04606082 -
Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI
|
N/A | |
| Not yet recruiting |
NCT04604054 -
The Effect of Granulocyte Colony Stimulating Factor Versus Human Chorionic Gonadotropin in Females With a History of RIF
|
N/A | |
| Not yet recruiting |
NCT04589793 -
COaching Lifestyle Intervention for FErtility
|
N/A | |
| Completed |
NCT06441409 -
Serum Ferritin Levels and Metabolic Dysfunction Associated Steatotic Liver Disease
|
N/A | |
| Completed |
NCT03846544 -
Double Pick up in Poor Prognosis Women
|
Phase 4 | |
| Completed |
NCT04141436 -
Hypnofertility for Women Undergoing In Vitro Fertilization (HWUIVF)
|
N/A | |
| Recruiting |
NCT05271981 -
Fertility After Uterine Artery Embolization
|
||
| Completed |
NCT03007043 -
Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response
|
||
| Completed |
NCT03161873 -
Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
|
||
| Completed |
NCT04133402 -
Fertility After Intrauterine Tamponing Balloon: Where Are we
|
||
| Active, not recruiting |
NCT06128395 -
ASA 81 mg vs 162 mg During Frozen Embryo Transfer (FET)
|
||
| Recruiting |
NCT05807256 -
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
|
||
| Completed |
NCT03908697 -
Quantum Natural Family Planning Pilot
|
N/A | |
| Completed |
NCT04908774 -
Effects of a Fasting Mimicking Diet on Sperm Quality
|
N/A | |
| Recruiting |
NCT05205733 -
Expanding Fertility Care to Poor and Low Resourced Settings Study
|
N/A | |
| Active, not recruiting |
NCT03085212 -
Strategies for Pregnancy Achievement
|
N/A |